J Thereaux1, C Barsamian2, M Bretault2, H Dusaussoy2, D Lamarque3, J-L Bouillot1, S Czernichow2,4, C Carette2. 1. Departments of General, Digestive and Metabolic Surgery, Ambroise Paré University Hospital, Versailles Saint-Quentin University, Assistance Publique - Hôpitaux de Paris, Boulogne, France. 2. Departments of Nutrition, Ambroise Paré University Hospital, Versailles Saint-Quentin University, Assistance Publique - Hôpitaux de Paris, Boulogne, France. 3. Departments of Gastroenterology, Ambroise Paré University Hospital, Versailles Saint-Quentin University, Assistance Publique - Hôpitaux de Paris, Boulogne, France. 4. Institut National de la Santé et de la Recherche Médicale UMS 011, Villejuif, France.
Abstract
BACKGROUND: Gastro-oesophageal reflux disease (GORD) is a common obesity-related co-morbidity that is assessed objectively by 24-h pH monitoring. Some concerns have been raised regarding the risk of de novo GORD or exacerbation of pre-existing GORD after laparoscopic sleeve gastrectomy. Here, 24-h pH monitoring was used to assess the influence of laparoscopic sleeve gastrectomy on postoperative GORD in obese patients with or without preoperative GORD. METHODS: From July 2012 to September 2014, all patients scheduled for laparoscopic sleeve gastrectomy were invited to participate in a prospective follow-up. Patients who underwent preoperative 24-h pH monitoring were asked to repeat the examination 6 months after operation. GORD was defined as an oesophageal pH < 4 for at least 4·2 per cent of the total time recorded. RESULTS: Of 89 patients, 76 had preoperative pH monitoring for GORD evaluation and 50 had postoperative reassessment. Patients without (group 1, 29 patients) or with (group 2, 21 patients) preoperative GORD were similar regarding age, sex ratio and body mass index. In group 1, the median (i.q.r.) total time at pH < 4 was significantly higher after surgery than before: 5·6 (2·5-9·5) versus 1·6 (0·7-2·9) per cent (P < 0·001). Twenty of the 29 patients experienced de novo GORD as determined by 24-h pH monitoring (P < 0·001). In group 2, total time at pH < 4 after surgery was no different from the preoperative value: 5·9 (3·9-10·7) versus 7·7 (5·2-10·3) per cent (P = 0·296). CONCLUSION: Laparoscopic sleeve gastrectomy was associated with de novo GORD in over two-thirds of patients, but did not seem to exacerbate existing GORD.
BACKGROUND: Gastro-oesophageal reflux disease (GORD) is a common obesity-related co-morbidity that is assessed objectively by 24-h pH monitoring. Some concerns have been raised regarding the risk of de novo GORD or exacerbation of pre-existing GORD after laparoscopic sleeve gastrectomy. Here, 24-h pH monitoring was used to assess the influence of laparoscopic sleeve gastrectomy on postoperative GORD in obesepatients with or without preoperative GORD. METHODS: From July 2012 to September 2014, all patients scheduled for laparoscopic sleeve gastrectomy were invited to participate in a prospective follow-up. Patients who underwent preoperative 24-h pH monitoring were asked to repeat the examination 6 months after operation. GORD was defined as an oesophageal pH < 4 for at least 4·2 per cent of the total time recorded. RESULTS: Of 89 patients, 76 had preoperative pH monitoring for GORD evaluation and 50 had postoperative reassessment. Patients without (group 1, 29 patients) or with (group 2, 21 patients) preoperative GORD were similar regarding age, sex ratio and body mass index. In group 1, the median (i.q.r.) total time at pH < 4 was significantly higher after surgery than before: 5·6 (2·5-9·5) versus 1·6 (0·7-2·9) per cent (P < 0·001). Twenty of the 29 patients experienced de novo GORD as determined by 24-h pH monitoring (P < 0·001). In group 2, total time at pH < 4 after surgery was no different from the preoperative value: 5·9 (3·9-10·7) versus 7·7 (5·2-10·3) per cent (P = 0·296). CONCLUSION: Laparoscopic sleeve gastrectomy was associated with de novo GORD in over two-thirds of patients, but did not seem to exacerbate existing GORD.
Authors: Jodok M Fink; Natalie Hoffmann; Simon Kuesters; Gabriel Seifert; Claudia Laessle; Torben Glatz; Ulrich T Hopt; W Konrad Karcz; Goran Marjanovic Journal: Obes Surg Date: 2017-04 Impact factor: 4.129
Authors: T Greilsamer; M de Montrichard; S Bruley des Varannes; D Jacobi; M Guillouche; N Regenet; E Mirallié; C Blanchard Journal: Obes Surg Date: 2020-04 Impact factor: 4.129
Authors: L Lallemand; E Duchalais; N Musquer; D Jacobi; E Coron; S Bruley des Varannes; E Mirallié; C Blanchard Journal: Obes Surg Date: 2020-07-29 Impact factor: 4.129
Authors: L Ulas Biter; Michiel M A van Buuren; Guido H H Mannaerts; Jan A Apers; Martin Dunkelgrün; Guy H E J Vijgen Journal: Obes Surg Date: 2017-10 Impact factor: 4.129
Authors: Jonathan Z Li; Ryan C Broderick; Estella Y Huang; Joaquin Serra; Samantha Wu; Michael Genz; Bryan J Sandler; Garth R Jacobsen; Santiago Horgan Journal: Surg Endosc Date: 2022-08-10 Impact factor: 3.453
Authors: Antonio Carlos Valezi; Fernando Augusto Herbella; Jorge Mali-Junior; Mariano de Almeida Menezes; Mário Liberatti; Rafael Onuki Sato Journal: Arq Bras Cir Dig Date: 2017 Jul-Sep